Core Viewpoint - Rosen Law Firm has announced a class action lawsuit against Picard Medical, Inc. for allegedly misleading investors regarding its business operations during the specified Class Period from September 2, 2025, to October 31, 2025 [1][2]. Allegations - The lawsuit claims that Picard Medical made materially false and misleading statements and failed to disclose significant adverse facts about its business and operations [3]. - Specific allegations include: 1. Involvement in a fraudulent stock promotion scheme utilizing social media misinformation and impersonation of financial professionals [3]. 2. Insiders and affiliates allegedly used offshore or nominee accounts to facilitate coordinated share dumping during a price inflation campaign [3]. 3. Public statements and risk disclosures from Picard omitted any mention of false rumors and artificial trading activity affecting stock prices [3]. 4. Positive statements made by the defendants regarding Picard's business and prospects were materially misleading and lacked a reasonable basis [3]. Participation in Class Action - Investors may be eligible to participate in the class action against Picard Medical, with a lead plaintiff representing other class members [4]. - Shareholders do not need to actively participate in the case to be eligible for recovery, and all representation is on a contingency fee basis, meaning no fees or expenses are incurred by shareholders [4]. About Rosen Law Firm - Rosen Law Firm is recognized for its active role in securities class actions and has successfully recovered over $1 billion for shareholders since its inception [5].

Core Viewpoint - Rosen Law Firm has initiated a class action lawsuit against F5, Inc. for allegedly misleading investors about its business operations and financial outlook during the specified class period from October 28, 2024, to October 27, 2025 [1][2]. Group 1: Allegations - The lawsuit claims that F5, Inc. misrepresented its revenue outlook and growth potential while downplaying risks associated with seasonality and macroeconomic factors [3]. - It is alleged that F5's optimistic statements regarding its security capabilities were misleading, as the company was experiencing a significant security incident that jeopardized both client security and F5's future prospects [3]. Group 2: Legal Proceedings - Shareholders interested in serving as lead plaintiffs must file motions with the court by February 17, 2026, and can choose to remain absent class members without participating in the case [4]. - The representation in this lawsuit is on a contingency fee basis, meaning shareholders will not incur any fees or expenses unless there is a recovery [5]. Group 3: About Rosen Law Firm - Rosen Law Firm is recognized for its commitment to shareholder rights litigation, having recovered over $1 billion for shareholders since its inception [6].